The Journal of Thoracic and Cardiovascular Surgery
Volume 126, Issue 4 , Pages 939-941 , October 2003

Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves?

  • Tirone E. David, MD

      Affiliations

    • Department of Surgery, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationAddress for reprints: Tirone E. David, MD, Department of Surgery, University of Toronto, 200 Elizabeth St, 13EN219, Toronto, Ontario M5G 2C4, Canada
    • ,
  • Joan Ivanov, PhD

      Affiliations

    • Department of Surgery, University of Toronto, Toronto, Ontario, Canada

Received 23 April 2003 ,Accepted 30 April 2003.

References 

  1. Agmon Y, Khandheria BK, Meissner I, et al.  Aortic valve sclerosis and aortic atherosclerosis (different manifestations of the same disease? Insights from a population-based study). J Am Coll Cardiol. 2001;38:827–834
  2. Otto CM, Kuusisto J, Reichenbak DD, Gown AM, O’Brien KD. Characterization of the early lesion of “degenerative” valvular aortic stenosis. Circulation. 1994;90:844–853
  3. O’Brien KD, Reinchenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apoliproteins B, (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Atheroscler Thromb Vasc Biol. 1996;16:523–532
  4. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693–695
  5. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723–1730
  6. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis (implications for secondary prevention). Circulation. 2000;101:2497–2502
  7. Novaro G, Tiong IY, Pearce BL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205–2209
  8. Veillard NR, Mach F. Statins (the new aspirin?). Cell Mol Life Sci. 2002;59:1771–1786
  9. Zornberg JH, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet. 2000;356:1627–1631
  10. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–1528
  11. Jian B, Narula N, Li Q, Mohler ER, Levy RJ. Progression of aortic valve stenosis (TGF-β1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis). Ann Thorac Surg. 2003;75:457–466
  12. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibition on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998;339:1972–1978
  13. Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg. 2001;71(suppl 5):S385–388
  14. Shen M, Marie P, Farge D, et al.  Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III. 1997;320:49–57
  15. Shimizaki Y, Kuraoka S, Takeda F, Watanabe T, Inui K. Mitral valve re-replacement for impaired biprosthesis after 19 years in a patient undergoing steroid treatment. J Heart Valve Dis. 2003;12:45–47
  16. Eishi K, Ishibashi-Ueda H, Nakano K, et al.  Calcific degeneration of bioprosthetic aortic valves in patients receiving steroid therapy. J Heart Valve Dis. 1996;5:668–672
  17. Liao K, Frater RWM, LaPietra A, Ciuffo G, Llardi CF, Seifter E. Time-dependent effect of glutaraldehyde on the tendency to calcify of both autolografts and xenografts. Ann Thorac Surg. 1995;60(suppl):S343–347
  18. Ogle MF, Kelly SJ, Bianco RW, Levy RJ. Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep. Ann Thorac Surg. 2003;75:1267–1273
  19. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg. 2003;126:965-8
  20. Farivar RS, Cohn LH. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg. 2003;126:969-76

PII: S0022-5223(03)00731-1

doi: 10.1016/S0022-5223(03)00731-1

The Journal of Thoracic and Cardiovascular Surgery
Volume 126, Issue 4 , Pages 939-941 , October 2003

Article Tools

* Image Usage & Resolution